Glioblastoma Clinical Trials in Raleigh, NC

Glioblastoma Clinical Trials in Raleigh, NC

View the best 10 glioblastoma medical studies in Raleigh, North Carolina. Access promising new therapies by applying to a Raleigh-based Glioblastoma clinical trial.

Trials in Raleigh, North Carolina

Here are the top 10 medical studies for glioblastoma in Raleigh, North Carolina

Image of Johns Hopkins Bayview Med Ctr in Baltimore, United States.

Dichloroacetate (DCA)

Metabolic Modulator

Recruiting1 awardPhase 2
This trial tests if DCA, a medication taken by mouth, can help treat patients with returning brain tumors who are scheduled for surgery. DCA may change how tumor cells use energy, potentially slowing their growth. DCA has shown potential activity against several human cancers, including brain tumors.
Image of Children's Hospital of Alabama in Birmingham, United States.

Tazemetostat

EZH2 Inhibitor

Recruiting1 awardPhase 2
This trial studies how well tazemetostat works in children with certain difficult-to-treat cancers that have specific gene mutations. Tazemetostat is a pill that aims to stop cancer cell growth by blocking a specific protein. The goal is to see if this treatment can help these children when other treatments have failed. Tazemetostat is already approved for treating various cancers, including certain brain tumors in children.
Image of Children's Hospital Los Angeles in Los Angeles, United States.

BGB-290 +1 More

PARP Inhibitor

Recruiting1 awardPhase 1
This trial studies the safety and best dose of BGB-290 and temozolomide in treating young people with a specific type of brain tumor. BGB-290 blocks enzymes needed for tumor growth, while temozolomide kills or stops cancer cells from growing. The goal is to find out if this combination works better for these patients.
Image of Children's Hospital Colorado in Aurora, United States.

Lutathera

Radioisotope Therapy

Recruiting1 awardPhase 1 & 2
This trial tests Lutathera, a radioactive drug given through an IV, in patients with certain brain tumors that haven't responded to other treatments. The drug attaches to cancer cells and uses radiation to kill them.
Image of Grandview Cancer Center in Birmingham, United States.

OptuneĀ®

Device

Recruiting1 award12 criteria
This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.
Image of City of Hope in Duarte, United States.

INO-5401 +4 More

Cancer Vaccine

Recruiting1 awardPhase 1 & 2
This trial is testing a new combination of drugs to treat glioblastoma, a type of brain cancer.
Image of Duke University in Durham, United States.

Atezolizumab

Checkpoint Inhibitor

Recruiting1 awardPhase 2
"This trial aims to see if giving atezolizumab before surgery can help patients with recurrent glioblastoma and low mutational burden."
Image of Lineberger Comprehensive Cancer Center in Chapel Hill, United States.

CAR.B7-H3T cells

CAR T-cell Therapy

Recruiting1 awardPhase 1
This trial is testing if it's safe to use CAR.B7-H3T cells, a treatment for glioblastoma that hasn't been tested on humans before.
Image of Valkyrie Clinical Trials in Beverly Hills, United States.

Pemigatinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a drug called pemigatinib for people with recurrent glioblastoma or other primary brain tumors. Pemigatinib will be given daily on a 2-week on, 1-week off schedule. The trial will enroll about 82 people in each of 3 cohorts.
Image of Mayo Clinic in Phoenix, United States.

Retifanlimab +3 More

Immune Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is testing a combination of treatments including a new drug, radiation therapy, and other medications for patients with aggressive brain cancer that has returned. The goal is to boost the body's immune system to better fight the cancer, shrink tumors, and help patients live longer.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.